Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.
This study has been completed.
Study NCT00417261
Information provided by Novartis
First Received on December 28, 2006.
Last Updated on June 20, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: